Amyris Sets Stage for Start-Up

Downstream Deals in Place; Commercial-scale Plants Come Online in 2012 The past year has been a critical one for synthetic biology firm Amyris (Emeryville, CA), as the newly public firm ramps up production of farnesene, a versatile C15 hydrocarbon that is the company’s first commercial product. Farnesene, which Amyris trade named Biofene, can be used as a platform chemical for producing fuels, polymers, and a number of specialty chemicals. Farnesene was not the company’s initial development target, however. Amyris originally set out in 2003 to develop yeast...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers